571 Eccles Avenue
South San Francisco, CA 94080
Phone: 650-873-0412

Casey Lynch, president and co-founder
Privately Held


Aspira Biosystems Inc. is a developer of advanced solutions for proteomics and pharmacogenomics. Aspira’s products are based on a patent-pending platform technology called ProteinPrint, which enables sequence-specific separation and high-throughput analysis of known and unknown proteins.

The technology is based on molecular imprinting, which facilitates the generation of well-defined cavities with a high affinity for a chosen target protein. It is similar to the base-pair hybridization used in mRNA analysis and genomics, in that a specific capture agent can be easily and predictably generated against any protein, even one that has never been isolated.